|
GB8504099D0
(en)
|
1985-02-18 |
1985-03-20 |
Wellcome Found |
Physiologically active substances
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
GB8610551D0
(en)
|
1986-04-30 |
1986-06-04 |
Hoffmann La Roche |
Polypeptide & protein derivatives
|
|
JPH0665280B2
(ja)
|
1987-03-04 |
1994-08-24 |
味の素株式会社 |
タンパクゲル化剤及びそれを用いるタンパクのゲル化方法
|
|
ATE198353T1
(de)
|
1988-08-24 |
2001-01-15 |
American Cyanamid Co |
Stabilisierung von somatotropinen durch modifikation von cystein-resten durch orts- spezifische mutagenese oder chemische derivatisierung
|
|
ATE189526T1
(de)
|
1988-10-28 |
2000-02-15 |
Genentech Inc |
Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
|
|
US6780613B1
(en)
|
1988-10-28 |
2004-08-24 |
Genentech, Inc. |
Growth hormone variants
|
|
US5534617A
(en)
|
1988-10-28 |
1996-07-09 |
Genentech, Inc. |
Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
|
|
JPH04504246A
(ja)
|
1989-03-20 |
1992-07-30 |
ザ・ジェネラル・ホスピタル・コーポレーション |
インシュリン刺激ホルモン
|
|
US5101018A
(en)
|
1989-06-12 |
1992-03-31 |
International Minerals & Chemical Corp. |
Method for recovering recombinant proteins
|
|
DE3930696A1
(de)
|
1989-09-14 |
1991-03-28 |
Hoechst Ag |
Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
|
|
WO1991011457A1
(en)
|
1990-01-24 |
1991-08-08 |
Buckley Douglas I |
Glp-1 analogs useful for diabetes treatment
|
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
|
US5951972A
(en)
|
1990-05-04 |
1999-09-14 |
American Cyanamid Company |
Stabilization of somatotropins and other proteins by modification of cysteine residues
|
|
JP2849773B2
(ja)
|
1990-08-27 |
1999-01-27 |
天野製薬株式会社 |
ストレプトミセス属由来のトランスグルタミナーゼの製造法
|
|
DK220890D0
(da)
|
1990-09-14 |
1990-09-14 |
Ole Buchardt |
Fremgangsmaade til fremstilling af c-terminalt amiderede peptider
|
|
JP3267293B2
(ja)
*
|
1990-12-03 |
2002-03-18 |
ジェネンテク,インコーポレイテッド |
改変された結合性を有する変異タンパク質の豊富化法
|
|
WO1992009690A2
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with altered binding properties
|
|
IT1251895B
(it)
*
|
1991-09-27 |
1995-05-26 |
Eniricerche Spa |
Mutanti dell'ormone della crescita umano e loro impiego
|
|
DE69333718T2
(de)
|
1992-01-14 |
2005-12-01 |
Ajinomoto Co., Inc. |
Gen, das für eine Fisch-Transglutaminase kodiert
|
|
ES2153385T5
(es)
|
1992-07-31 |
2008-09-01 |
Genentech, Inc. |
Composicion acuosa a base de hormona del crecimiento humana.
|
|
ZA936811B
(en)
|
1992-10-28 |
1995-03-15 |
Upjohn Co |
Somatotropin modifications
|
|
US5359030A
(en)
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
WO1995020662A1
(en)
|
1994-01-28 |
1995-08-03 |
Ajinomoto Co., Inc. |
Transglutaminase originating in japanese oyster
|
|
JP3720363B2
(ja)
|
1994-08-26 |
2005-11-24 |
ノボザイムス アクティーゼルスカブ |
微生物のトランスグルタミナーゼ、それらの産生及び使用
|
|
US6010871A
(en)
|
1994-09-29 |
2000-01-04 |
Ajinomoto Co., Inc. |
Modification of peptide and protein
|
|
DE4437604A1
(de)
|
1994-10-21 |
1996-04-25 |
Basf Ag |
Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung
|
|
ATE248219T1
(de)
|
1995-01-19 |
2003-09-15 |
Novozymes As |
Transglutaminasen aus oomyzeten
|
|
JP3669390B2
(ja)
|
1995-02-09 |
2005-07-06 |
味の素株式会社 |
バチルス属細菌由来のトランスグルタミナーゼ
|
|
US5869602A
(en)
|
1995-03-17 |
1999-02-09 |
Novo Nordisk A/S |
Peptide derivatives
|
|
DE851925T1
(de)
|
1995-09-21 |
2003-08-14 |
Genentech Inc., San Francisco |
Varianten des menschlichen wachstumshormons
|
|
US20020077461A1
(en)
|
1996-04-24 |
2002-06-20 |
Soren Bjorn |
Pharmaceutical formulation
|
|
WO1998008872A1
(en)
|
1996-08-30 |
1998-03-05 |
Novo Nordisk A/S |
Glp-2 derivatives
|
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
ES2283025T3
(es)
|
1996-08-30 |
2007-10-16 |
Novo Nordisk A/S |
Derivados de glp-1.1.
|
|
EP0950665A4
(en)
|
1996-09-26 |
2004-05-06 |
Ajinomoto Kk |
PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM
|
|
US5985627A
(en)
|
1997-02-28 |
1999-11-16 |
Carlsberg Laboratory |
Modified carboxypeptidase
|
|
JPH1156378A
(ja)
*
|
1997-06-11 |
1999-03-02 |
Nippon Chem Res Kk |
変異型ヒト成長ホルモンとその用途
|
|
PT996629E
(pt)
|
1997-06-25 |
2006-12-29 |
Applied Research Systems |
Análogos de hormonas glicoproteicas reticulados com ligações dissulfito, sua preparação e utilização
|
|
EP1012184B1
(en)
|
1997-07-14 |
2007-10-10 |
Bolder Biotechnology, Inc. |
Derivatives of growth hormone and related proteins
|
|
JPH1192499A
(ja)
*
|
1997-09-22 |
1999-04-06 |
Sumitomo Pharmaceut Co Ltd |
ヒト成長ホルモン変異体
|
|
US6136536A
(en)
|
1997-10-29 |
2000-10-24 |
Genetics Institute, Inc. |
Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
|
|
AU2610799A
(en)
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
Glp-1 derivatives with helix-content exceeding 25 per cent, forming partially structured micellar-like aggregates
|
|
JP2002504527A
(ja)
|
1998-02-27 |
2002-02-12 |
ノボ ノルディスク アクティーゼルスカブ |
部分的に組織化したミセル様凝集物を形成する25%を越えるヘリックス成分を有するglp−2誘導体
|
|
WO1999043705A1
(en)
|
1998-02-27 |
1999-09-02 |
Novo Nordisk A/S |
N-terminally truncated glp-1 derivatives
|
|
WO1999043708A1
(en)
|
1998-02-27 |
1999-09-02 |
Novo Nordisk A/S |
Glp-1 derivatives of glp-1 and exendin with protracted profile of action
|
|
DE69942307D1
(de)
|
1998-02-27 |
2010-06-10 |
Novo Nordisk As |
N-terminal veränderte glp-1 abkömmlinge
|
|
US6656922B2
(en)
|
1998-05-28 |
2003-12-02 |
Mediplex Corporation, Korea |
Oral delivery of macromolecules
|
|
US6358705B1
(en)
|
1998-07-16 |
2002-03-19 |
Novo Nordisk A/S |
Method of making proteins in transformed yeast cells
|
|
SG125915A1
(en)
|
1998-12-07 |
2006-10-30 |
Sod Conseils Rech Applic |
Analogues of glp-1
|
|
US6329336B1
(en)
|
1999-05-17 |
2001-12-11 |
Conjuchem, Inc. |
Long lasting insulinotropic peptides
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
WO2001004287A1
(en)
|
1999-07-07 |
2001-01-18 |
Maxygen Aps |
A method for preparing modified polypeptides
|
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
|
US6528486B1
(en)
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
|
GB2355009A
(en)
|
1999-07-30 |
2001-04-11 |
Univ Glasgow |
Peptides conjugated to bile acids/salts
|
|
US20040001827A1
(en)
|
2002-06-28 |
2004-01-01 |
Dennis Mark S. |
Serum albumin binding peptides for tumor targeting
|
|
EP1250126A2
(en)
|
2000-01-11 |
2002-10-23 |
Novo Nordisk A/S |
Transepithelial delivery of glp-1 derivatives
|
|
WO2001058935A2
(en)
|
2000-02-11 |
2001-08-16 |
Maxygen Aps |
FACTOR VII OR VIIa-LIKE MOLECULES
|
|
CA2405550A1
(en)
|
2000-04-12 |
2001-10-25 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
NZ522847A
(en)
*
|
2000-05-16 |
2004-11-26 |
Bolder Biotechnology Inc |
Methods for refolding proteins containing free cysteine residues
|
|
US20020142964A1
(en)
|
2000-11-02 |
2002-10-03 |
Nissen Torben Lauesgaard |
Single-chain polypeptides
|
|
DK1355942T3
(da)
|
2000-12-07 |
2008-11-17 |
Lilly Co Eli |
GLP-1-fusionsproteiner
|
|
US20060183197A1
(en)
|
2001-01-11 |
2006-08-17 |
Andersen Kim V |
Variant growth hormone molecules conjugated with macromolecules compounds
|
|
AU2002219021A1
(en)
|
2001-01-11 |
2002-07-24 |
Maxygen Aps |
Variant growth hormone molecules conjugated with macromolecular compounds
|
|
FR2819810B1
(fr)
|
2001-01-23 |
2004-05-28 |
Pf Medicament |
Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin
|
|
US6858580B2
(en)
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
EP2110385A1
(en)
|
2001-06-14 |
2009-10-21 |
The Scripps Research Institute |
Stabilized factor VIII with engineered disulfide bonds
|
|
DK1412384T3
(da)
|
2001-06-28 |
2008-04-28 |
Novo Nordisk As |
Stabil formulering af modificeret GLP-1
|
|
EP1423136A4
(en)
|
2001-08-10 |
2007-07-25 |
Epix Pharm Inc |
POLYPEPTIDE CONJUGATES HAVING INCREASED CIRCULATION HALF-VIES
|
|
AR036711A1
(es)
|
2001-10-05 |
2004-09-29 |
Bayer Corp |
Peptidos que actuan como agonistas del receptor del glp-1 y como antagonistas del receptor del glucagon y sus metodos de uso farmacologico
|
|
JP2005518786A
(ja)
|
2001-11-12 |
2005-06-30 |
ユニバーシティ カレッジ カーディフ コンサルタンツ リミテッド |
ヒトにおける成長ホルモン変異とその用途
|
|
WO2003044056A2
(en)
|
2001-11-20 |
2003-05-30 |
Pharmacia Corporation |
Chemically-modified human growth hormone conjugates
|
|
JP2003199569A
(ja)
|
2001-12-17 |
2003-07-15 |
Food Industry Research & Development Inst |
ストレプトベルティシリウム・ラダカヌムのトランスグルタミナーゼ遺伝子及び該遺伝子によってコードされるトランスグルタミナーゼ
|
|
FR2836382B1
(fr)
|
2002-02-28 |
2004-08-13 |
Biomerieux Sa |
Nouveaux agents de couplages, leurs conjugues, ainsi que l'utilisation de ces conjugues dans des methodes de diagnostic
|
|
EP1587944A4
(en)
|
2002-03-01 |
2007-03-21 |
Dyax Corp |
KDR AND VEGF / KDR BINDING PEPTIDES AND THEIR USE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
|
|
US20050164925A1
(en)
|
2002-04-10 |
2005-07-28 |
Joseph Anthony Jakubowski And Thurman Dwight Mc Kinney |
Treatment of gastroparesis
|
|
PL373728A1
(en)
|
2002-04-30 |
2005-09-05 |
Maxygen Holdings Ltd. |
Factor vii or viia polypeptide variants
|
|
US7611700B2
(en)
|
2002-09-09 |
2009-11-03 |
Hanall Pharmaceuticals, Co., Ltd. |
Protease resistant modified interferon alpha polypeptides
|
|
EP2067483A1
(en)
|
2003-02-19 |
2009-06-10 |
Ipsen Pharma |
Analogues of GLP-1
|
|
JP2007524584A
(ja)
|
2003-05-09 |
2007-08-30 |
ノボ ノルディスク アクティーゼルスカブ |
肥満の治療に使用するペプチド
|
|
EP1654004A2
(en)
|
2003-08-08 |
2006-05-10 |
Novo Nordisk A/S |
Synthesis and application of new structural well defined branched polymers as conjugating agents for peptides
|
|
RU2401276C2
(ru)
|
2003-09-19 |
2010-10-10 |
Ново Нордиск А/С |
Производные глюкагон-подобного пептида-1 (glp-1)
|
|
EP1667724A2
(en)
|
2003-09-19 |
2006-06-14 |
Novo Nordisk A/S |
Albumin-binding derivatives of therapeutic peptides
|
|
CN100444898C
(zh)
|
2003-09-19 |
2008-12-24 |
诺沃挪第克公司 |
治疗肽的清蛋白结合型衍生物
|
|
TW200526254A
(en)
|
2003-09-19 |
2005-08-16 |
Novo Nordisk As |
Novel GLP-1 derivatives
|
|
CN100580087C
(zh)
|
2003-10-10 |
2010-01-13 |
诺和诺德医疗保健公司 |
肽的缀合
|
|
CN101665538A
(zh)
|
2003-12-18 |
2010-03-10 |
诺沃挪第克公司 |
与白蛋白样物质相连的新glp-1类似物
|
|
ATE461217T1
(de)
|
2003-12-18 |
2010-04-15 |
Novo Nordisk As |
Glp-1-verbindungen
|
|
CA2552043A1
(en)
|
2004-01-21 |
2005-08-04 |
Novo Nordisk A/S |
Transglutaminase mediated conjugation of peptides
|
|
BRPI0507159A
(pt)
|
2004-02-02 |
2007-06-26 |
Ambrx Inc |
polipeptìdeos em feixe de quatro hélices humanos modificados e seus usos
|
|
UA89781C2
(uk)
|
2004-04-07 |
2010-03-10 |
Арес Трейдінг С.А. |
Рідкий склад гормона росту
|
|
US7906137B2
(en)
|
2004-05-21 |
2011-03-15 |
Mediplex Corporation, Korea |
Delivery agents for enhancing mucosal absorption of therapeutic agents
|
|
MXPA06015049A
(es)
|
2004-07-08 |
2007-02-08 |
Novo Nordisk As |
Marcadores prolongadores de polipeptidos que comprenden una porcion tetrazol.
|
|
US20090176967A1
(en)
|
2004-08-02 |
2009-07-09 |
Novo Nordisk Healthcare A/G |
Conjugation of FVII
|
|
US7893017B2
(en)
|
2004-10-07 |
2011-02-22 |
Novo Nordisk A/S |
Protracted GLP-1 compounds
|
|
US7998930B2
(en)
*
|
2004-11-04 |
2011-08-16 |
Hanall Biopharma Co., Ltd. |
Modified growth hormones
|
|
CA2594561C
(en)
|
2004-12-22 |
2014-12-23 |
Ambrx, Inc. |
Formulations of human growth hormone comprising a non-naturally encoded amino acid
|
|
TWI372629B
(en)
|
2005-03-18 |
2012-09-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
MX2007011307A
(es)
|
2005-03-18 |
2007-10-08 |
Novo Nordisk As |
Compuestos de glp-1 extendidos.
|
|
EP1863537A2
(en)
|
2005-03-18 |
2007-12-12 |
Novo Nordisk A/S |
Dimeric peptide agonists of the glp-1 receptor
|
|
WO2006134173A2
(en)
|
2005-06-17 |
2006-12-21 |
Novo Nordisk Health Care Ag |
Selective reduction and derivatization of engineered proteins comprising at least one non-native cysteine
|
|
WO2007020291A1
(en)
|
2005-08-18 |
2007-02-22 |
Novo Nordisk Health Care Ag |
Improving transglutaminase substrate specificity
|
|
US8293708B2
(en)
|
2005-08-30 |
2012-10-23 |
Novo Nordisk Health Care A/G |
Liquid formulations N-terminal serine of pegylated growth hormone
|
|
CN1939534B
(zh)
|
2005-09-27 |
2010-12-01 |
长春金赛药业股份有限公司 |
含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
|
|
CN101384711A
(zh)
*
|
2006-01-19 |
2009-03-11 |
Ambrx公司 |
具有经调节的免疫原性的非天然氨基酸多肽
|
|
EP1986694B1
(en)
|
2006-02-14 |
2015-06-10 |
Novo Nordisk Health Care AG |
Coupling of polypeptides at the c-terminus
|
|
WO2008003750A2
(en)
|
2006-07-07 |
2008-01-10 |
Novo Nordisk Health Care Ag |
New protein conjugates and methods for their preparation
|
|
ES2745411T3
(es)
|
2006-07-27 |
2020-03-02 |
Wang Nai Fang |
Compuestos y composiciones de arilsulfanilo para administración de agentes activos
|
|
JP2010500886A
(ja)
|
2006-08-18 |
2010-01-14 |
ノボ ノルディスク ヘルス ケア アーゲー |
改善された特異性を有するトランスグルタミナーゼ変異体
|
|
US20080095837A1
(en)
|
2006-08-31 |
2008-04-24 |
Emisphere Technologies, Inc. |
Human growth hormone formulations
|
|
PL2059260T3
(pl)
|
2006-08-31 |
2014-03-31 |
Novartis Ag |
Kompozycja farmaceutyczna obejmująca hGH do dostarczania doustnego
|
|
US8383852B2
(en)
|
2007-02-16 |
2013-02-26 |
Emisphere Technologies, Inc. |
Compounds having a cyclic moiety and compositions for delivering active agents
|
|
WO2008112836A2
(en)
|
2007-03-15 |
2008-09-18 |
Novartis Ag |
Pharmaceutical composition comprising human growth hormon
|
|
WO2009030771A1
(en)
|
2007-09-05 |
2009-03-12 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
|
MX2011000847A
(es)
|
2008-08-06 |
2011-02-25 |
Novo Nordisk Healthcare Ag |
Proteinas conjugadas con eficacia prolongada in vivo.
|
|
EP2324056A1
(en)
|
2008-09-09 |
2011-05-25 |
Novo Nordisk Health Care AG |
Growth hormone conjugate with increased stability
|
|
US8637647B2
(en)
|
2008-09-12 |
2014-01-28 |
Novo Nordisk A/S |
Method of acylating a peptide or protein
|
|
CN102292349B
(zh)
|
2009-01-22 |
2016-04-13 |
诺沃—诺迪斯克保健股份有限公司 |
稳定的生长激素化合物
|
|
CN102333788A
(zh)
|
2009-02-19 |
2012-01-25 |
诺沃—诺迪斯克有限公司 |
因子viii的修饰
|
|
CN102612376A
(zh)
|
2009-08-06 |
2012-07-25 |
诺沃-诺迪斯克保健股份有限公司 |
具有延长的体内功效的生长激素
|
|
US9211342B2
(en)
|
2010-01-22 |
2015-12-15 |
Novo Nordisk Healthcare Ag |
Stable growth hormone compounds resistant to proteolytic degradation
|
|
MX345736B
(es)
|
2010-01-22 |
2017-02-14 |
Novo Nordisk Healthcare Ag |
Hormonas de crecimiento con eficacia in vivo prolongada.
|
|
WO2011101261A2
(en)
|
2010-02-16 |
2011-08-25 |
Novo Nordisk A/S |
Purification method
|